Selective recognition of M235T angiotensinogen variants and their determination in human plasma by monoclonal antibody-based immunoanalysis

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3505-3512

  Cohen, Pascale ^a   Badouaille, Gabriel ^a   Gimenez Roqueplo, Anne Paule ^b   Mani, Jean Claude ^c   Guyene, Tahn Tam ^b   Jeunemaitre, Xavier ^b   Menard, Joël ^b   Corvol, Pierre ^b   Pau, Bernard ^c   Simon, Dominique ^a  

^a SANOFI   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; MONOCLONAL ANTIBODY; SERINE PROTEINASE INHIBITOR;

ANGIOTENSIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE REGULATION; GENETIC LINKAGE; HUMAN; IMMUNOCHEMISTRY; MATERNAL HYPERTENSION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSINOGEN; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; EPITOPE MAPPING; GENOTYPE; HUMANS; IMMUNORADIOMETRIC ASSAY; IMMUNOSORBENT TECHNIQUES; MUTATION;

EID: 10244220005     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3505     Document Type: Article

References (48)

1. Tewksbury DA. 1990 Angiotensinogen: biochemistry and molecular biology. In: Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press; 1197-1296.
2. Lynch KR, Peach MJ. 1991 Molecular biology of angiotensinogen. Hypertension. 17:263-269.
3. Doolittle RF. 1983 Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family. Science. 222:417-419.
4. Walker WG, Whelton PK, Saito H, Patterson Russel R, Hermann J. 1978 Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension. 1:287-291.
5. Fasola AF, Martz BL, Helmer OM. 1968 Plasma renin activity during supine exercise in offspring of hypertensive parents. J Appl Physiol. 25:410-415.
6. Watt GCM, Harrap SB, Foy CJW, et al. 1992 Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens. 10:473-482.
7. Menard J, El Amrani AI, Savoie F, Bouhnik K. 1991 Angiotensinogen: an attractive and underrated participant in hypertension and inflammation. Hypertension. 18:705-706.
8. Gardes J, Bouhnik J, Clauser E, Menard J. 1982 Role of angiotensinogen in blood pressure homeostasis. Hypertension. 4:185-189.
9. Ohkubo H, Kageyama R, Ujihara M, Hirose T, Inayama S, Nakanishi S. 1983 Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci USA. 80:2196-2200.
10. Kimura S, Mullins JJ, Brunnemann B, et al. 1992 High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J. 11:821-827.
11. Kim HS, Krege JH, Kluckman KD, et al. 1995 Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA. 92:2735-2739.
12. Ward R. 1990 In: Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press; 81-100.
13. Jeunemaitre X, F Soubrier, YV Kotelevtsev, et al. 1992 Molecular basis of human hypertension: role of angiotensinogen. Cell. 71:169-180.
14. Caulfield M, Lavender P, Farrall M, et al. 1994 Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 330:1629-1633.
15. Jeunemaitre X, Charru A, Chatellier G, et al. 1993 M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens. 11 [Suppl 5]:S80-S81.
16. Hata A, Namikawa C, Sasaki M, et al. 1994 Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 93:1285-1287.
17. Kamitani A, Raguki H, Higaki J, et al. 1994 Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens. 8:521-524.
18. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. 1995 Angiotensinogen gene and blood pressure in the Japanese population. Hypertension. 25:688-693.
19. 235→Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem. Biophys Res Commun. 197:833-839.
20. Rotimi C, Morrison L, Cooper R, et al. 1994 Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension. 24:591-594.
21. Hegele RA, Brunt JH, Connelly PW. 1994 A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation. 90:2207-2212.
22. Morise T, Takeuchi Y, Takeda R. 1995 Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. J Intern Med. 237:175-180.
23. Ward K, Hata A, Jeunemaitre X, et al. 1993 A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet. 4:59-61.
24. Katsuya T, Koike G, Yee TW, et al. 1995 Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 345:1600-1603.
25. Ishigami T, Umemura S, Iwamoto T, et al. 1995 Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation. 91:951-954.
26. Kamitani A, Raguki H, Higaki J, et al. 1995 Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension. 25:950-953.
27. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt HJ. 1995 The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 95:948-953.
28. Wallmark A, Alm R, Eriksson S. 1984 Monoclonal antibody specific for the mutant PIZ α1-antitrypsin and its application in an ELISA procedure for identification of PIZ gene carriers. Proc Natl Acad Sci USA. 81:5690-5693.
29. Skriver K, Wikoff WR, Patston PA, et al. 1991 Substrate properties of C, inhibitor Ma (alanine 434→glutamic acid). J Biol Chem. 266:9216-9221.
30. Dawes J, James K, Lane DA. 1994 Conformational change in antithrombin induced by heparin, probed with a monoclonal antibody against 1C/4B region. Biochemistry. 33:4375-4383.
31. Mizrahi J, Coezy E, Auzan C, Corvol P, Menard J. 1987 Monoclonal antibodies to human angiotensinogen: development of an ELISA for measurement of hepatocyte cultured cells content. Clin Exp Hypertens. [A] 9:1479-1491.
32. 2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 15:429-436.
33. Charru A, Jeunemaitre X, Soubrier F, Corvol P, Chatellier G. 1993 HYPERGENE: a clinical and genetic database for genetic analysis of human hypertension. J Hypertens. 12:981-985.
34. Sambrook J, Fritch FF, Maniatis T. 1989 In: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
35. Cohen P, Simon D, Badouaille G, Mani JC, Portefaix JM, Pau B. 1995 New monoclonal antibodies directed against the propart segment of human prorenin as a tool for the exploration of prorenin conformation. J Immunol Methods. 184:91-100.
36. Larue C, Calzolari C, Leger J, Leger Joc, Pau B. 1991 Immunoradiometric assay of myosin heavy chain fragments in plasma for investigation of myocardial infarction. Clin Chem. 37:78-82.
37. Genain C, Bouhnik J, Tewksbury D, Corvol P, Menard J. 1984 Characterization of plasma and cerebrospinal fluid human angiotensinogen and desangiotensinogen I-angiotensinogen by direct radioimmunoassay. J Clin Endocrinol Metab. 59:478-484.
38. Nakane PK, Kawaoi A. 1974 Peroxidase-labelled antibody. A new method of conjugation. J Histochem Cytochem. 22:1084-1091.
39. Dubs MC, Altschuh D, Van Regenmortel MHV. 1992 Interaction between viruses and monoclonal antibodies studied by surface plasmon resonance. Immunol Lett. 31:59-64.
40. Jonsson U, Fagerstam L, Ivarson B, et al. 1991 Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques. 11:620-627.
41. Malmqvist M. 1993a Biospecific interaction analysis using biosensor technology. Nature. 361:186-187.
42. Malmqvist M. 1993b Surface plasmon resonance for detection and measurement of antibody-antigen affinity and kinetics. Curr Opin Immunol. 5:282-286.
43. O'Shanessy DJ, Brigham-Burke M, Sonseson KK, Hensley P, Brooks I. 1994 Determination of rate and equilibrium binding constants for macromolecular interactions by surface plasmon resonance. Methods Enzymol. 240:323-349.
44. Huber R, RW Carrell. 1989 Implications of the three-dimensional structure of α1-antitrypsin for structure and function of serpins. Biochemistry. 28:8951-8966.
45. Löbermann H, Tokuoka R, Deisenhofer J, Huber R. 1984 Human α1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol. 177:531-557.
46. Gimenez-Roqueplo AP, Leconte I, Cohen P, et al. 1996 The natural mutation Y248C of human angiotensinogen leads to abnormal glycosylation and altered immunological recognition of the protein. J Biol Chem. 271:9838-9844.
47. Watton J, Longstaff C, Lane DA, Barrowcliffe TW. 1993 Heparin binding affinity or normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III. Biochemistry. 32:7286-7293.
48. Mille B, Watton J, Barrowcliffe TW, Mani JC, Lane DA. 1994 Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide. J Biol Chem. 269:29435-29443.